Stock Scorecard

Stock Summary for PharmaCyte Biotech Inc (PMCB) - $0.78 as of 12/3/2025 8:42:46 PM EST

Total Score

18 out of 30

Safety Score

34 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for PMCB

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PMCB

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PMCB

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PMCB

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PMCB (34 out of 100)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 3
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 10
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 9
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Financial Details for PMCB

Company Overview
Ticker PMCB
Company Name PharmaCyte Biotech Inc
Country USA
Description PharmaCyte Biotech Inc. (PMCB) is a clinical-stage biotechnology firm based in Laguna Hills, California, specializing in innovative cell therapies for cancer and diabetes. Leveraging its proprietary technology platform, the company is dedicated to developing transformative treatments designed to improve patient outcomes and enhance quality of life. With a strong focus on advancing its clinical programs, PharmaCyte Biotech is strategically positioned to address critical unmet medical needs, thereby driving potential value for institutional investors in the dynamic biopharmaceutical landscape.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 7/31/2025
Next Earnings Date 12/12/2025

Stock Price History
Last Day Price 0.78
Price 4 Years Ago 2.50
Last Day Price Updated 12/3/2025 8:42:46 PM EST
Last Day Volume 667,148
Average Daily Volume 2,051,489
52-Week High 1.90
52-Week Low 0.63
Last Price to 52 Week Low 23.81%

Valuation Measures
Trailing PE 12.50
Industry PE 43.11
Sector PE 88.06
5-Year Average PE -3.89
Free Cash Flow Ratio 0.40
Industry Free Cash Flow Ratio 13.81
Sector Free Cash Flow Ratio 28.78
Current Ratio Most Recent Quarter 18.01
Total Cash Per Share 1.94
Book Value Per Share Most Recent Quarter 6.42
Price to Book Ratio 0.12
Industry Price to Book Ratio 33.69
Sector Price to Book Ratio 33.12
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 31.75
Sector Price to Sales Ratio Twelve Trailing Months 15.97
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics
Total Shares Outstanding 6,795,800
Market Capitalization 5,300,724
Institutional Ownership 6.38%

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 10.30%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 9,084.98%
Reported EPS 12 Trailing Months 0.06
Reported EPS Past Year -1.23
Reported EPS Prior Year 2.66
Net Income Twelve Trailing Months -1,125,514
Net Income Past Year 30,656,050
Net Income Prior Year 333,763
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%
Operating Margin Twelve Trailing Months 0.00%

Balance Sheet
Total Cash Most Recent Quarter 13,178,305
Total Cash Past Year 15,172,163
Total Cash Prior Year 50,179,968
Net Cash Position Most Recent Quarter 13,178,305
Net Cash Position Past Year 15,172,163
Long Term Debt Past Year 0
Long Term Debt Prior Year 75,200
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 51,891,069
Total Stockholder Equity Prior Year 39,514,619
Total Stockholder Equity Most Recent Quarter 43,591,588

Free Cash Flow
Free Cash Flow Twelve Trailing Months -4,598,988
Free Cash Flow Per Share Twelve Trailing Months -0.68
Free Cash Flow Past Year -2,978,300
Free Cash Flow Prior Year -2,151,460

Options
Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.06
MACD Signal -0.06
20-Day Bollinger Lower Band 0.74
20-Day Bollinger Middle Band 0.93
20-Day Bollinger Upper Band 1.12
Beta 0.05
RSI 52.84
50-Day SMA 1.21
150-Day SMA 1.95
200-Day SMA 2.08

System
Modified 12/2/2025 6:48:39 AM EST